A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial".
Wenke MorisGer H KoekCees Th B M van DeursenPublished in: American journal of hematology (2022)